Status:
COMPLETED
A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers
Lead Sponsor:
Shire
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
This is a drug-drug interaction study; the purpose of this study is to examine the pharmacokinetics (levels of drug in the blood) of SPD503 (guanfacine hydrochloride) and Concerta (methylphenidate HCl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects must be normal healthy adult volunteers with no significant abnormalities in medical history, physical exam, vital signs or lab evaluations at the screening visit
Exclusion
Key Trial Info
Start Date :
May 18 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 6 2009
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00901576
Start Date
May 18 2009
End Date
July 6 2009
Last Update
June 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advanced Biomedical Research, Inc.
Hackensack, New Jersey, United States, 07601